GMNN and medulloblastoma: We therefore examined Gmnn expression levels in human medulloblastomas based on molecular and histological subtypes, sex, and several other criteria (presence of a β-catenin mutation, staging, time of diagnosis), using two medulloblastoma expression datasets.